Novel Bi-heterocycles as Potent Inhibitors of Urease and Less Cytotoxic Agents: 3-({5-((2-Amino-1,3-thiazol-4-yl)methyl)-1,3,4-oxadiazol- 2-yl}sulfanyl)-N-(un/substituted-phenyl)propanamides

Document Type : Research article


1 Department of Chemistry, Government College University, Lahore-54000, Pakistan.

2 Institute of Molecular Biology and Biotechnology, The University of Lahore, Pakistan.

3 Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia.

4 Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Level 9, FF3, Universiti Teknologi MARA, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia.

5 Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur-63100, Pakistan.

6 Department of Biochemistry, University of Agriculture, Faisalabad-38040, Pakistan.

7 Department of Biological Sciences, College of Natural Sciences, Kongju National University, Gongju, 32588, South Korea.


The synthesis of a novel series of bi-heterocyclic propanamides, 7a-l, was accomplished by S-substitution of 5-[(2-amino-1,3-thiazol-4-yl)methyl]-1,3,4-oxadiazol-2-thiol (3). The synthesis was initiated from ethyl 2-(2-amino-1,3-thiazol-4-yl)acetate (1) which was converted to corresponding hydrazide, 2, by hydrazine hydrate in methanol. The refluxing of hydrazide, 2, with carbon disulfide in basic medium, resulted in 5-[(2-amino-1,3-thiazol-4-yl)methyl]-1,3,4-oxadiazol-2-thiol (3). A series of electrophiles, 6a-l, was synthesized by stirring un/substituted anilines (4a-l) with 3-bromopropanoyl chloride (5) in a basic aqueous medium. Finally, the targeted compounds, 7a-l, were acquired by stirring 3 with newly synthesized electrophiles, 6a-l, in DMF using LiH as a base and an activator. The structures of these bi-heterocyclic propanamides were confirmed through spectroscopic techniques, such as IR, 1H-NMR, 13C-NMR, and EI-MS. These molecules were tested for their urease inhibitory potential, whereby, the whole series exhibited very promising activity against this enzyme. Their cytotoxic behavior was ascertained through hemolysis and it was observed that all these were less cytotoxic agents. The in-silico molecular docking analysis of these molecules was also in full agreement with their in-vitro enzyme inhibition data.

Graphical Abstract

Novel Bi-heterocycles as Potent Inhibitors of Urease and Less Cytotoxic Agents: 3-({5-((2-Amino-1,3-thiazol-4-yl)methyl)-1,3,4-oxadiazol- 2-yl}sulfanyl)-N-(un/substituted-phenyl)propanamides


Main Subjects

(1) Samadhiya P, Sharma Srivasta RD and SrivastavaSK. Construction of some new bioactive buildingblock of thiazolidines. Acta Chim. Slov. (2012) 59:632–40.
(2) Doss ML and Lalitha KG. Synthesis andantimicrobial screening of novel mono and tri schiffbases of thiazole derivatives. Sci. Revs. Chem.Commun. (2011) 1: 49–57.
(3) Nevagi RJ. Biological and medicinal significance of2-aminothiazoles. Pharm. Lett. (2014) 6: 134–50.
(4) Kistayya C, Rao NGR, Nayak BS and Sonar VN.Synthesis and evaluation of antibacterial activityof some 2-amino/substituted amino-4-(phenyl/pchlorophenyl) thiazoles. J. Adv. Sci. Res. (2013) 4:1–5.
(5) Li Z, Zhan P and Liu X. 1,3,4-oxadiazole: aprivileged structure in antiviral agents. Mini-Rev.Med. Chem. (2011) 11: 1130–42.
(6) Joshi D and Parikh KS. Synthesis and antimicrobialevaluation of 1,3,4-oxadiazole-based chalconederivatives. Med. Chem. Res. (2014) 23: 1855–64.
(7) Bondock S, Adel S, Etman HA and Badria FA.Synthesis and antitumor evaluation of some new1,3,4-oxadiazole-based heterocycles. Eur. J. Med.Chem. (2012) 48: 192-9.
(8) Patel RV, Kumari P and Chikhalia KH. Newquinolinyl-1,3,4-oxadiazoles: Synthesis, in-vitroantibacterial, antifungal and antituberculosis studies.Med. Chem. (2013) 9: 596–607.
(9) Sahoo BM, Dinda SC, Kumar BVVR, PandaJ, Brahmkshatriya PS. Design, green synthesis,and anti-inflammatory activity of schiff base of1,3,4-oxadiazole analogues. Lett. Drug Des. Discov.(2014) 11: 82–9.
(10) Gupta A, Kashaw SK, Jain N, Rajak H, Soni A andStables JP. Design and synthesis of some novel3-[5-(4-substituted)phenyl-1,3,4-oxadiazole2yl]-2-phenylquinazoline-4(3H)-ones as possibleanticonvulsant agent. Med. Chem. Res. (2011) 20:1638–42.
(11) Sanchit S and Pandeya SN. Various approaches for synthesis of oxadiazole derivatives. Int. J. Res.Ayurveda. Pharm. (2011) 2: 459-68.
(12) Coppo FT, Evans KA, Graybill TL and Burton G. Efficient one-pot preparation of 5-substituted2-amino-1,3,4-oxadiazoles using resin-boundreagents. Tetrahedron Lett. (2004) 45: 3257–60.
(13) Yang SJ, Lee SH, Kwak HJ and Gong YD.Regioselective synthesis of 2-amino-substituted1,3,4-oxadiazole and 1,3,4-thiadiazole derivativesvia reagent-based cyclization of thiosemicarbazideintermediate. J. Org. Chem. (2013) 78: 438–44.
(14) Brown BJ, Clemens IR and Neesom JK.Diisopropylcarbodiimide: A novel reagent for thesynthesis of 1,3,4-oxadiazoles on solid-phase.Synlett (2000) 2000: 131–3.
(15) Shang Z, Reiner J, Chang J and Zhao K. Oxidativecyclization of aldazines with bis(trifluoroacetoxy)iodobenzene. Tetrahedron Lett. (2005) 46: 2701–4.
(16) Dabiria M, Salehib P, Baghbanzadeha M andBahramnejada M. A facile procedure for the onepot synthesis of unsymmetrical 2,5-disubstituted1,3,4-oxadiazoles. Tetrahedron Lett. (2005) 47:6983-6.506
(17) Brain CT, Paul JM, Loong Y and Oakley PJ. Novelprocedure for the synthesis of 1,3,4-oxadiazolesfrom 1,2-diacylhydrazines using polymersupported Burgess reagent under microwave conditions. Tetrahedron Lett. (1999) 40: 3275–8.
(18) Patel KN, Jadhav NC, Jagadhane PB and TelvekarVN. A novel strategy for the construction of azoleheterocycles via an oxidative desulfurizationapproach using iodobenzene and oxone. Synlett(2012) 23: 1970–2.
(19) de Oliveira CS, Lira BF, Barbosa-Filho JM, LorenzoJGF and de Athayde-Filho PF. Synthetic approachesand pharmacological activity of 1,3,4-oxadiazoles: Areview of the literature from 2000–2012. Molecules(2012) 17: 10192–231.
(20) Lodhi MA, Hussain J, Abbasi MA, Jassbi AR andChoudhary MI. A new Bacillus pasteurii ureaseInhibitor from Euphorbia decipiens. J. EnzymeInhib. Med. Chem. (2006) 21: 531–5.
(21) Lodhi MA, Abbasi MA, Choudhary MI and AhmadVU. Kinetics studies on triacontanyl palmitate: aurease inhibitor. Nat. Prod. Res. (2007) 21: 721–5.
(22) Kitchen DB, Decornez H, Furr JR and Bajorath J.Docking and scoring in virtual screening for drugdiscovery: methods and applications. Nat. Rev.Drug Discov. (2004) 3: 935–49.
(23) Abbasi MA, Hassan M, Aziz-ur-Rehman, SiddiquiSZ, Raza H, Shah SAA and Seo SY. Synthesis, invitro and in-silico studies of novel potent ureaseinhibitors: N-[4-({5-[(3-Un/substituted-anilino3-oxopropyl)sulfanyl]-1,3,4-oxadiazol-2-yl}methyl)-1,3-thiazol-2-yl]benzamides. Bioorg.Med. Chem. (2018) 26: 3791-804.
(24) Mobley HLT, Island MD and Hausinger RP.Molecular biology of microbial ureases. Microbiol.Rev. (1995) 59: 451-80.
(25) Sharma P and Sharma JD. In-vitro hemolysisof human erythrocytes by plant extracts with
antiplasmodial activity. J. Ethnopharmacol. (2001)74: 239–43.
(26) Abbasi MA, Islam M, Aziz-ur-Rehman, Rasool S,Rubab K, Hussain G, Ahmad I, Ashraf M, ShahidM and Shah SAA. Synthesis, characterization,antibacterial, α-glucosidase inhibition and hemolytic studies on some new N-(2,3-dimethylphenyl)benzenesulfonamide derivatives.Trop. J. Pharm. Res. (2016) 15: 591–8.
(27) Dallakyan S and Olson AJ. Small-molecule libraryscreening by docking with PyRx. Methods Mol.Biol. (2015) 1263: 243-50.
(28) Pettersen EF, Goddard TD, Huang CC, Couch GS,Greenblatt DM, Meng EC and Ferrin TE. UCSFChimera--a visualization system for exploratoryresearch and analysis. J. Comput. Chem. (2004) 25:1605-12.
(29) Carter EL, Flugga N, Boer JL, Mulrooney SB andHausinger RP. Interplay of metal ions and urease.Metallomics (2009) 1: 207-21.
(30) Saeed A, Mahesar PA, Channar PA, Larik FA,Abbas Q, Hassan M, Raza H and Seo SY. Hybridpharmacophoric approach in the design andsynthesis of coumarin linked pyrazolinyl as ureaseinhibitors, kinetic mechanism and moleculardocking. Chem. Biodivers. (2017) 14: e1700035.
(31) Abdul Fattah T, Saeed A, Channar PA, AshrafZ, Abbas Q, Hassan M and Larik FA. Synthesis,enzyme inhibitory kinetics, and computationalstudies of novel 1-(2-(4-isobutylphenyl)propanoyl)-3-arylthioureas as Jack bean ureaseinhibitors. Chem. Biol. Drug Des. (2018) 91: 434-47.